Notably, serum levels of MMP-1 and -3 in RA patients have been well known to correlate with the disease activity [100], and thus, MMP-3 is a practically useful marker for predicting bone and cartilage damage and evaluating therapeutic efficacy in RA [101]. This evidence concerns the gene MMP1 and rheumatoid arthritis.